Clinical Trial Update: Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing indacaterol 75 μg to placebo in patients with moderate to severe COPD to assess time to patient-perceived onset of effect; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2013-05-03